The oral solid dosage (OSD) forms—tablets, capsules, and granules—are essential to the global pharmaceutical market, dominating prescriptions due to their convenience and cost-effectiveness. However, the path to market for new products is fraught with scientific and regulatory challenges, including bioequivalence studies and GMP requirements. Collaboration with a suitable Contract Research Organization (CRO) is crucial for manufacturers. Zenovel provides comprehensive CRO solutions, leveraging expertise in GCP, GMP, and Regulatory Affairs to support the entire product lifecycle from development to commercialization.
Challenges for OSD Manufacturers
Regulatory Expectations:
Regulatory agencies like the FDA, EMA, and WHO are increasingly focusing on data integrity, quality management, and risk-based oversight in pharmaceuticals. For manufacturers of solid oral dosage (OSD) forms, compliance must be demonstrated throughout the development process. The FDA’s ICH M13A guideline outlines recommendations for conducting bioequivalence studies of immediate-release tablets and capsules, stressing the importance of study design, data analysis, and adherence to regulatory standards to ensure the safety and efficacy of generic drugs.
Bioequivalence for Generic Approval
For generic OSD manufacturers, establishing bioequivalence is essential for approval. Bioequivalence studies show that generics release active ingredients comparably to brand-name drugs, using pharmacokinetic parameters like AUC and Cmax within 80–125% of the reference. Without proving bioequivalence, generics cannot substitute brand-name drugs, affecting their affordability and availability. Even simple BE studies demand rigorous processes to ensure data integrity and compliance.
GMP Compliance
GMP is critical to all stages of OSD product development, ensuring product quality, controlled manufacturing, appropriate validation, effective change management, and precise documentation. Inadequate GMP frameworks can lead to delays in technology transfer, process validation, stability studies, and regulatory submissions.
Documentation Burden
OSD manufacturers are required to maintain comprehensive documentation during the development lifecycle, including clinical study protocols, reports, CMC documentation, and regulatory submissions. Even small inconsistencies can lead to delays in review, regulatory inquiries, or requests for additional information. Zenovel provides high-impact solutions in the pharmaceutical industry, focusing on GCP, GMP, and Regulatory Affairs. With extensive industry experience and a global presence across India, the USA, Canada, and the EU, Zenovel offers exceptional expertise.
GCP Services for Clinical Development Excellence
Zenovel provides a comprehensive suite of clinical trial services from Phase I to IV, including bioequivalence and pharmacokinetic studies. Key capabilities include Risk-Based Monitoring (RBM) to enhance trial efficiency and ensure patient safety; a PK-Stat Review for regulatory evidence from pharmacokinetic data; and tailored clinical monitoring services by GCP experts. With extensive experience in trial oversight, including GCP monitoring engagements, Zenovel also assists in the setup and upgrading of CROs to maintain GCP compliance and optimize processes.
GMP compliant for regulatory compliance
Zenovel specializes in designing GMP-compliant pharmaceutical and biotech projects by leveraging its expertise in production plant design, local building resources, and regulatory requirements.
We offer key GMP capabilities, including conducting audits at numerous global manufacturing sites and providing a comprehensive GMP Audit Report Library. Our cGMP consulting services aim to expedite drug development while ensuring regulatory compliance through supply chain audits and quality system improvements. We also assist in GMP plant setup and upgrades to align with WHO-GMP and PIC/S standards. Additionally, Zenovel helps clients manage GMP documentation, focusing on document hierarchy and version control.
Regulatory Affairs for Navigating Global Pathways
Zenovel’s regulatory team specializes in managing complex regulatory challenges, providing services that guarantee timely submissions and compliance. Our capabilities include extensive dossier preparation and submission experience, expertise in eCTD software for both EU and US submissions, gap assessments for various markets, and a team with years of experience in regulatory strategy design and implementation.
CMC Development Services
Zenovel provides extensive CMC development services for the pharmaceutical and biotechnology sectors, employing advanced methodologies for effective product development, scaling, and launch. Our offerings include dosage form design and optimization and formulation development for solids, liquids, and injectables, as well as prototype development and evaluation.
Pre-Inspection Readiness
Zenovel prepares facilities and staff for FDA and regulatory inspections, offering support for inspection readiness. This proactive strategy enables manufacturers to identify and address gaps before inspections, reducing the risk of regulatory findings that could delay development schedules.
Zenovel offers integrated clinical, quality, and regulatory solutions essential for OSD manufacturers to achieve market success. With expertise in GCP, GMP, and Regulatory Affairs, Zenovel supports drug development through bioequivalence studies, clinical monitoring, and regulatory submissions, thereby accelerating timelines and minimizing risks while ensuring high-quality products reach patients faster.
Zenovel offers comprehensive CRO solutions to accelerate your oral solid dosage development program. Contact Zenovel to learn more about supporting your next product launch.
